Ironwood Pharmaceuticals | IRWD - Current Assets



Ironwood Pharmaceuticals reported $182.42M in Current Assets for its fiscal quarter ending in December of 2024.


Current Assets Change Date
Acadia Pharmaceuticals USD 960.55M 89.61M Jun/2025
Agios Pharmaceuticals USD 1.02B 50.85M Jun/2025
Almirall EUR 714.05M 50.55M Jun/2025
Alnylam Pharmaceuticals USD 3.64B 375.44M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
Ardelyx USD 351.57M 4.88M Jun/2025
Astellas Pharma JPY 1.29T 91.98B Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Charles River Laboratories USD 1.47B 36.5M Jun/2025
Exact Sciences USD 1.51B 137.52M Jun/2025
Halozyme Therapeutics USD 1.12B 139.35M Jun/2025
Incyte USD 3.64B 411.91M Jun/2025
Ironwood Pharmaceuticals USD 182.42M 3.81M Dec/2024
MacroGenics USD 204.94M 12.55M Jun/2025
Moderna USD 6.17B 595M Jun/2025
Myriad Genetics USD 287.2M 10.8M Mar/2025
Pacira USD 745.61M 14.35M Jun/2025
PTC Therapeutics USD 2.27B 43.53M Jun/2025
Sarepta Therapeutics USD 2.66B 224.45M Jun/2025
Takeda JPY 2.51T 8.07B Jun/2025
Ultragenyx Pharmaceutical USD 719.79M 20.63M Jun/2025